This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Freshpet (FRPT) Tops Q2 Earnings Estimates
by Zacks Equity Research
Freshpet (FRPT) delivered earnings and revenue surprises of +175.00% and -1.25%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Ingredion (INGR) Tops Q2 Earnings Estimates
by Zacks Equity Research
Ingredion (INGR) delivered earnings and revenue surprises of +3.24% and -3.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
US Foods (USFD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
US Foods (USFD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Vanguard S&P Mid-Cap 400 Value ETF (IVOV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOV
Costco's June Sales Climb on Robust 11.5% E-Commerce Growth
by Zacks Equity Research
COST posts 5.8% June comp sales growth, fueled by strong 11.5% e-commerce gains and steady demand from value-focused shoppers.
Should Value Investors Buy US Foods (USFD) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is US Foods (USFD) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
US Foods (USFD) could produce exceptional returns because of its solid growth attributes.
Should iShares S&P Mid-Cap 400 Value ETF (IJJ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IJJ
Should SPDR S&P 400 Mid Cap Value ETF (MDYV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MDYV
Should Vanguard S&P Mid-Cap 400 Value ETF (IVOV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOV
Should iShares S&P Mid-Cap 400 Value ETF (IJJ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IJJ
US Foods (USFD) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
US Foods (USFD) delivered earnings and revenue surprises of -1.45% and 0.37%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
US Foods (USFD) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
US Foods (USFD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Utz Brands (UTZ) Meets Q1 Earnings Estimates
by Zacks Equity Research
Utz Brands (UTZ) delivered earnings and revenue surprises of 0% and 0.01%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Should SPDR S&P 400 Mid Cap Value ETF (MDYV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MDYV
Should Vanguard S&P Mid-Cap 400 Value ETF (IVOV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOV
Should iShares S&P Mid-Cap 400 Value ETF (IJJ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IJJ
MED Q4 Earnings Beat, Revenues Dip Y/Y on Lower Customer Acquisition
by Zacks Equity Research
Medifast's Q2 results show challenges related to weak customer acquisition. However, it is prioritizing efforts to enhance coach productivity in the near term.
CL Set to Expand Hill's Pet Nutrition With the Prime100 Acquisition
by Zacks Equity Research
Colgate-Palmolive plans to expand its pet nutrition portfolio with the acquisition of Prime100, reinforcing its commitment to premium, science-backed pet food.
Monster Beverage Stock Falls 8% in 3 Months: Should You Buy the Dip?
by Zacks Equity Research
MNST faces near-term challenges, including decelerating U.S. energy drink growth and currency impacts, but its long-term growth potential remains compelling.
Newell Stock Drops 30% in a Month: Is It Still Worth Your Money?
by Zacks Equity Research
NWL faces near-term headwinds, but strategic initiatives and margin expansion offer long-term recovery potential.
THS Q4 Earnings Miss While Sales Beat Estimates, Volume Rises Y/Y
by Zacks Equity Research
TreeHouse Foods Q4 results reflect lower net sales but higher earnings. The gross margin expands y/y due to the effective execution of supply-chain savings initiatives.
US Foods Q4 Earnings Surpass Estimates, Sales Increase Y/Y
by Zacks Equity Research
USFD delivers a strong fiscal fourth-quarter performance, driven by growth in total independent case volume.
Should You Add Colgate Stock to Your Portfolio Post Q4 Earnings?
by Zacks Equity Research
CL faces near-term headwinds. But its strong pricing strategy, premium innovation and brand-building investments lay the foundation for long-term growth.
SCI Q4 Earnings Top Estimates on Cemetery & Funeral Revenue Growth
by Zacks Equity Research
Service Corporation's Q4 results reflect revenue growth across Cemetery and Funeral units and lower corporate, general and administrative costs.